• SU6656 Src Tyrosine Kinases Inhibitor Workflows

  2026-08-13

  SU6656 offers a practical way to interrogate Src-dependent megakaryocyte maturation while supporting separate preclinical radiotherapy studies. This guide translates the latest hiPSC-platelet optimization findings into executable workflows, controls, and troubleshooting decisions.

• CUDC-907 Protocol for Dual PI3K and HDAC Inhibition

  2026-08-12

  CUDC-907 is a dual PI3K and HDAC inhibitor for controlled in vitro studies of pathway signaling, epigenetic responses, cell-cycle distribution, and apoptosis. This guide translates the product dossier into a practical workflow and defines boundaries for research use; it is not intended for diagnostic, therapeutic, or clinical applications.

• Caffeic Acid Phenethyl Ester in NF-κB Workflows

  2026-08-12

  Caffeic Acid Phenethyl Ester (CAPE) provides a practical chemical perturbation strategy for separating NF-κB-dependent inflammation from Fyn–Stat3 signaling in neurodegeneration models. This guide connects zebrafish imaging, mammalian cell assays, formulation control, and carefully bounded anti-angiogenesis applications.

• MLN2238: Reading Proteasome Stress Signals

  2026-08-11

  MLN2238 is a proteasome β5 subunit inhibitor that can serve as both a target-engagement reagent and a probe of proteotoxic-stress signaling. This article connects its concentration-dependent proteasome profile with ROS/JNK/CREB biology and practical assay decisions in oncology and proteostasis research.

• Probenecid: A Translational Map for Transporter Biology

  2026-08-10

  Probenecid is more than a conventional transporter inhibitor. By combining MRP and organic anion transporter modulation with pannexin-1 inhibition, 4-(dipropylsulfamoyl)benzoic acid offers a useful translational probe for connecting drug efflux, inflammatory injury, and cellular stress across oncology and neuroscience.

• Oncostatin M as a Translational Cytokine Control Point

  2026-08-09

  A thought-leadership guide to using Recombinant Human Oncostatin M as a controlled variable in cell-state, proliferation, cytokine-release, and oncology-oriented translational research.

• AT-406 (SM-406) in Apoptosis Research

  2026-08-08

  AT-406 (SM-406) is a practical multi-IAP antagonist for connecting target engagement with caspase processing, PARP cleavage, chemotherapy sensitization, and oral xenograft studies. This workflow-focused guide shows how to design, interpret, and troubleshoot AT-406 experiments without confusing IAP inhibition with direct disruption of the death-inducing signaling complex.

• CFDA SE Cell Tracer Kit: Practical Guide

  2026-08-07

  The CFDA SE Cell Tracer Kit provides covalent fluorescent labeling for long-term cell tracking, cell proliferation studies, and lineage-oriented experiments. It is appropriate when persistent labeling is required, but not when the experiment needs reversible, rapidly cleared, or strictly short-term cell marking.

• PD98059 in Vascular Lipidomics: Unlocking MEK Inhibition Ins

  2026-08-07

  Explore how PD98059, a selective MEK inhibitor, advances our understanding of vascular lipid accumulation after nanoplastic exposure. This in-depth analysis reveals novel applications for PD98059 in lipid metabolism and cardiovascular research.

• TGF-β Regulation of Sca-1 and Plasticity in Mammary Stem Cel

  2026-08-06

  This study uncovers how TGF-β signaling dynamically regulates Sca-1 expression and cellular plasticity in pre-neoplastic mammary epithelial stem cells, linking surface marker modulation to tumorigenic potential. The findings clarify mechanisms of stemness and lineage commitment, providing a foundation for targeted modulation of TGF-β pathways in cancer research.

• EdU Flow Cytometry Assay Kits (Cy5): Precision S-Phase Detec

  2026-08-06

  EdU Flow Cytometry Assay Kits (Cy5) deliver robust, denaturation-free detection of S-phase DNA synthesis for advanced cell proliferation analysis. Optimized for flow cytometry, these kits streamline multiplex workflows and drive translational research in oncology and immunology.

• PD98059 MEK Inhibitor: Optimizing MAPK/ERK Pathway Assays

  2026-08-05

  PD98059 empowers researchers to probe the MAPK/ERK pathway with precision, enabling advanced workflows in cancer, apoptosis, and neuroprotection studies. This article dives into practical protocol enhancements and troubleshooting, leveraging both the latest cardiovascular findings and established research best practices.

• E-64d: Precision Calpain Inhibition for Cell Death Research

  2026-08-05

  E-64d empowers researchers to dissect cysteine protease roles in regulated cell death with high selectivity and robust intracellular penetration. This guide details advanced workflow strategies, troubleshooting, and protocol optimization for apoptosis, platelet activation, and neuroprotection models—anchored by the latest insights from lysoptosis research.

• Pentoxifylline Dampens Hyperinflammation in Preterm Monocyte

  2026-08-04

  This study demonstrates that pentoxifylline (PTX) robustly downregulates LPS-induced inflammatory responses in monocytes from preterm infants, including reduced surface marker expression and cytokine production. The findings highlight age-specific immunomodulatory effects and provide mechanistic insights into PTX’s anti-inflammatory role in neonatal sepsis models.

• Balancing Self-Renewal and Differentiation in Human Intestin

  2026-08-04

  This study introduces a tunable human intestinal organoid system that achieves controlled equilibrium between stem cell self-renewal and differentiation by leveraging small molecule pathway modulators. The innovation enables the generation of organoids with both high proliferative capacity and increased cellular diversity, advancing applications in tissue modeling and high-throughput screening.

449 records 8/30 page Previous Next First page 上5页 678910 下5页 Last page